Flexeril vs. Pregabalin: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Flexeril and Pregabalin. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 421,396 people who take Flexeril and Pregabalin, and is updated regularly.
What is Flexeril?
Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.
What is Pregabalin?
Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.
421,396 people who take Flexeril and Pregabalin are studied.

Drugs being compared in this study:
- Pregabalin (pregabalin)
- Flexeril (cyclobenzaprine hydrochloride)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Flexeril:
- not at all: 3.93 %
- somewhat: 29.22 %
- moderate: 37.03 %
- high: 23.28 %
- very high: 6.53 %
Pregabalin:
- not at all: 5.96 %
- somewhat: 25.92 %
- moderate: 33.58 %
- high: 24.92 %
- very high: 9.61 %
Want to compare Flexeril with Pregabalin?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
Related studies
Alternative drugs to, pros and cons of:
- Flexeril (34,811 reports)
- Pregabalin (73,061 reports)
Browse all side effects of Flexeril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pregabalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on cyclobenzaprine hydrochloride and pregabalin (the active ingredients of Flexeril and Pregabalin, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Valproate Sodium and Rashes for Women aged 40-49 - a second ago
- Valproate Sodium and Rash Generalised for Women aged 40-49 - a second ago
- Valproate Sodium and Rash for Women aged 40-49 - 2 seconds ago
- Valproate Sodium and Skin Redness Or Inflammation for Women aged 40-49 - 2 seconds ago
- Valproate Sodium and Skin Lesion for Women aged 40-49 - 2 seconds ago
- Valproate Sodium and Rubor for Women aged 40-49 - 3 seconds ago
- Valproate Sodium and Erythema for Women aged 40-49 - 3 seconds ago
- Valproate Sodium and Skin Rash for Women aged 40-49 - 3 seconds ago
- Could Lyrica cause Spinal Column Injury? - 5 seconds ago
- Fainting and drugs of ingredients of emtricitabine; tenofovir alafenamide fumarate - 15 seconds ago